CAT<sub>3</sub>, a prodrug of 13a(S)-3-hydroxyl-6,7-dimethoxyphenanthro[9,10-b]-indolizidine, circumvents temozolomide-resistant glioblastoma via the Hedgehog signaling pathway, independently of O<sup>6</sup>-methylguanine DNA methyltransferase expression

Original Research

CAT₃, a prodrug of 13a(S)-3-hydroxyl-6,7-dimethoxyphenanthro[9,10-b]-indolizidine, circumvents temozolomide-resistant glioblastoma via the Hedgehog signaling pathway, independently of O⁶-methylguanine DNA methyltransferase expression

Total article views		HTML views	PDF downloads	Totals
8,822	Dovepress*	8,176+	897	9,073
	PubMed Central*	646	162	808
	Totals	8,822	1,059	9,881
*Since 25 June 2018